newsfilter
← Latest News
PR Newswire·

MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program

Provisional Patent Filed on Non-Racemic Ibogaine Mixtures VANCOUVER, BC, March 2, 2022 /PRNewswire/ - Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology for mental heal